Showing results (21-30 of 59) with videos related to

Sort By:
Pageof 6
European Heart Journal|February 24, 2010
Anti-apolipoprotein A-1 IgG as an independent cardiovascular prognostic marker affecting basal heart rate in myocardial infarctionNicolas Vuilleumier, Michel F Rossier, Sabrina Pagano, et al.
Plos One|September 9, 2020
Identification of immunodominant linear epitopes from SARS-CoV-2 patient plasmaLluc Farrera-Soler, Jean-Pierre Daguer, Sofia Barluenga, et al.
Frontiers in Cardiovascular Medicine|June 4, 2024
Anti-apolipoprotein A-1 IgG, incident cardiovascular events, and lipid paradox in rheumatoid arthritisDenis Mongin, Sabrina Pagano, Celine Lamacchia, et al.
Journal of Translational Medicine|October 5, 2023
Antibody against apolipoprotein-A1, non-alcoholic fatty liver disease and cardiovascular risk: a translational studySabrina Pagano, Stephan J L Bakker, Catherine Juillard, et al.
Arthritis and Rheumatism|May 28, 2010
Anti-apolipoprotein A-1 IgG predicts major cardiovascular events in patients with rheumatoid arthritisNicolas Vuilleumier, Sylvette Bas, Sabrina Pagano, et al.
Frontiers in Cardiovascular Medicine|February 28, 2024
People living with HIV display increased anti-apolipoprotein A1 auto-antibodies, inflammation, and kynurenine metabolites: a case-control studyMiguel A Frias, Sabrina Pagano, Nasim Bararpour, et al.
Frontiers in Immunology|May 2, 2017
Anti-Apolipoprotein A-1 IgG Predict All-Cause Mortality and Are Associated with Fc Receptor-Like 3 PolymorphismsPanagiotis Antiochos, Pedro Marques-Vidal, Julien Virzi, et al.
Frontiers in Immunology|March 13, 2025
Association between SARS-CoV-2 infection and anti-apolipoprotein A-1 antibody in childrenNicolas Vuilleumier, Sabrina Pagano, Elsa Lorthe, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 28, 2017
Impact of CD14 Polymorphisms on Anti-Apolipoprotein A-1 IgG-Related Coronary Artery Disease Prediction in the General PopulationPanagiotis Antiochos, Pedro Marques-Vidal, Julien Virzi, et al.
Pageof 6